Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

BACKGROUND:<br>Familial hypercholesterolaemia (FH) is an inherited lipid disorder causing premature heart disease, which is severely underdiagnosed. Improving the identification of people with FH in primary care settings would help to reduce avoidable heart attacks and early deaths. AIM:To eva...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Akyea, RK, Qureshi, N, Kai, J, de Lusignan, S, Sherlock, J, McGee, C, Weng, S
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Royal College of General Practitioners 2020

Eitemau Tebyg

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study
gan: Ralph K Akyea, et al.
Cyhoeddwyd: (2020-11-01)

Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care
gan: Stephen Weng, PhD, et al.
Cyhoeddwyd: (2019-05-01)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
gan: Joe Kai, et al.
Cyhoeddwyd: (2021-12-01)

Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
gan: Ralph K. Akyea, et al.
Cyhoeddwyd: (2020-10-01)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
gan: Joe Kai, et al.
Cyhoeddwyd: (2021-12-01)

Familial hypercholesterolaemia
gan: D.J. Blom
Cyhoeddwyd: (2011-01-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
gan: Minhas, R, et al.
Cyhoeddwyd: (2009)

Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study
gan: Anis Safura Ramli, et al.
Cyhoeddwyd: (2023-06-01)

Familial hypercholesterolaemia.
gan: Gill, P, et al.
Cyhoeddwyd: (2012)

Statins and familial hypercholesterolaemia.
gan: Neil, A, et al.
Cyhoeddwyd: (2009)

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
gan: Nadeem Qureshi, et al.
Cyhoeddwyd: (2023-10-01)

EASILY MISSED? Familial hypercholesterolaemia
gan: Gill, P, et al.
Cyhoeddwyd: (2012)

Familial Hypercholesterolaemia: An Updated Overall Management
gan: Mohd Kasim, Noor Alicezah, et al.
Cyhoeddwyd: (2020)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
gan: Vallejo-Vaz, Antonio J., et al.
Cyhoeddwyd: (2020)

Familial Hypercholesterolaemia – a targeted Next Generation Sequencing panel and retrospective analysis of patients with no previously identified pathogenic variant
gan: E. Willis, et al.
Cyhoeddwyd: (2022-10-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
gan: Marks, D, et al.
Cyhoeddwyd: (2000)

Novel molecular therapies for the treatment of familial hypercholesterolaemia
gan: Kerr, A
Cyhoeddwyd: (2016)

International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
gan: Gerald F. Watts, et al.
Cyhoeddwyd: (2024-01-01)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
gan: Anastasia V. Poznyak, et al.
Cyhoeddwyd: (2022-10-01)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
gan: Maria Elena Capra, et al.
Cyhoeddwyd: (2023-06-01)

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
gan: J. Cegla, et al.
Cyhoeddwyd: (2023-12-01)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
gan: Humphries, SE, et al.
Cyhoeddwyd: (2005)

A perspective for sequencing familial hypercholesterolaemia in African Americans
gan: Wright, Michelle L, et al.
Cyhoeddwyd: (2018)

Commentary: What's so special about familial hypercholesterolaemia?
gan: Mant, D
Cyhoeddwyd: (2009)

Recent advances in the management and implementation of care for familial hypercholesterolaemia
gan: Nick S.R. Lan, et al.
Cyhoeddwyd: (2023-08-01)

Hypercholesterolaemia treatment in a patient with family hypercholesterolaemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors
gan: P. Luque Linero, et al.
Cyhoeddwyd: (2022-04-01)

Assessment of GENinCode in the Diagnosis of Patients with Suspected Familial Hypercholesterolaemia
gan: P.E. Carey, et al.
Cyhoeddwyd: (2022-10-01)

An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
gan: J. Webster, et al.
Cyhoeddwyd: (2022-10-01)

Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study
gan: Merete Heitmann, et al.
Cyhoeddwyd: (2024-02-01)

Inclisiran for the treatment of hypercholesterolaemia
gan: Joel C Marrs, et al.
Cyhoeddwyd: (2024-11-01)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
gan: S.E. Humphries, et al.
Cyhoeddwyd: (2023-12-01)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
gan: Marks, D, et al.
Cyhoeddwyd: (2003)

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
gan: Marks, D, et al.
Cyhoeddwyd: (2002)

Triple-combined hypolipidaemic therapy in familial hypercholesterolaemia: clinical cases
gan: Svetlana A. Chepurnenko, et al.
Cyhoeddwyd: (2021-10-01)

Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia
gan: E. Ofagbor, et al.
Cyhoeddwyd: (2023-12-01)

Genetics in familial hypercholesterolaemia – from genetic research to new guidelines
gan: Edyta Kinga Prokop, et al.
Cyhoeddwyd: (2019-04-01)

Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
gan: Alexander R.M. Lyons, et al.
Cyhoeddwyd: (2024-03-01)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
gan: Neil, A, et al.
Cyhoeddwyd: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
gan: Neil, H, et al.
Cyhoeddwyd: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
gan: Neil, H, et al.
Cyhoeddwyd: (2004)